-
1
-
-
0030573421
-
Update: Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV
-
CDC. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR 1996;45:468-72.
-
(1996)
MMWR
, vol.45
, pp. 468-472
-
-
-
2
-
-
0032523426
-
Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis
-
CDC. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. MMWR 1998;47(No. RR-7):1-33.
-
(1998)
MMWR
, vol.47
, Issue.RR-7
, pp. 1-33
-
-
-
3
-
-
0035968189
-
Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis
-
CDC. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 2001;50 (No. RR-11):1-52.
-
(2001)
MMWR
, vol.50
, Issue.RR-11
, pp. 1-52
-
-
-
4
-
-
13744249434
-
Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: Recommendations from the U.S. Department of Health and Human Services
-
CDC. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR 2005;54(No. RR-2):1-20.
-
(2005)
MMWR
, vol.54
, Issue.RR-2
, pp. 1-20
-
-
-
6
-
-
0037639784
-
Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus
-
Havens PL; Committee on Pediatric AIDS. Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics 2003;111:1475-89.
-
(2003)
Pediatrics
, vol.111
, pp. 1475-1489
-
-
Havens, P.L.1
-
7
-
-
0030831196
-
Occupational risk of human immunodeficiency virus infection in health-care workers: An overview
-
Bell DM. Occupational risk of human immunodeficiency virus infection in health-care workers: an overview. Am J Med 1997;102(5B):9-15.
-
(1997)
Am J Med
, vol.102
, Issue.5 B
, pp. 9-15
-
-
Bell, D.M.1
-
8
-
-
0022445589
-
Horizontal transmission of HIV infection between two siblings
-
Wahn V, Kramer HH, Voit T, Bruster HT, Scrampical B, Scheid A. Horizontal transmission of HIV infection between two siblings. Lancet 1986;ii:694.
-
(1986)
Lancet
, vol.2
, pp. 694
-
-
Wahn, V.1
Kramer, H.H.2
Voit, T.3
Bruster, H.T.4
Scrampical, B.5
Scheid, A.6
-
9
-
-
0023667562
-
Transmission of HIV by human bite
-
Anonymous. Transmission of HIV by human bite. Lancet 1987;ii:522.
-
(1987)
Lancet
, vol.2
, pp. 522
-
-
-
10
-
-
0027536801
-
The potential for transmission of human immunodeficiency virus through human bites
-
Richman KM, Rickman LS. The potential for transmission of human immunodeficiency virus through human bites. J Acquir Immune Defic Syndr 1993;6:402-6.
-
(1993)
J Acquir Immune Defic Syndr
, vol.6
, pp. 402-406
-
-
Richman, K.M.1
Rickman, L.S.2
-
11
-
-
0029949815
-
Transmission of HIV-1 by human bite
-
Vidmar L, Poljak M, Tomazic J, Seme K, Klavs I. Transmission of HIV-1 by human bite. Lancet 1996;347:1762.
-
(1996)
Lancet
, vol.347
, pp. 1762
-
-
Vidmar, L.1
Poljak, M.2
Tomazic, J.3
Seme, K.4
Klavs, I.5
-
12
-
-
0032855376
-
Human bites and the risk of human immunodeficiency virus transmission
-
Pretty IA, Anderson GS, Sweet DJ. Human bites and the risk of human immunodeficiency virus transmission. Am J Forensic Med Pathol 1999;20:232-9.
-
(1999)
Am J Forensic Med Pathol
, vol.20
, pp. 232-239
-
-
Pretty, I.A.1
Anderson, G.S.2
Sweet, D.J.3
-
14
-
-
3042726798
-
Treatment for adult HIV infection: 2004 Recommendations of the International AIDS Society-USA Panel
-
Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 2004;292:251-65.
-
(2004)
JAMA
, vol.292
, pp. 251-265
-
-
Yeni, P.G.1
Hammer, S.M.2
Hirsch, M.S.3
-
15
-
-
0034545637
-
Experience of health-care workers taking postexposure prophylaxis after occupational human immunodeficiency virus exposures: Findings of the HIV Postexposure Prophylaxis Registry
-
Wang SA, Panlilio AL, Doi PA, et al. Experience of health-care workers taking postexposure prophylaxis after occupational human immunodeficiency virus exposures: findings of the HIV Postexposure Prophylaxis Registry. Infect Control Hosp Epidemiol 2000;21:780-5.
-
(2000)
Infect Control Hosp Epidemiol
, vol.21
, pp. 780-785
-
-
Wang, S.A.1
Panlilio, A.L.2
Doi, P.A.3
-
16
-
-
0032414572
-
Occupational exposure to HIV: Experience at a tertiary care center
-
Swotinsky RB, Steger KA, Sulis C, Snyder S, Craven DE. Occupational exposure to HIV: experience at a tertiary care center. J Occup Environ Med 1998;40:1102-9.
-
(1998)
J Occup Environ Med
, vol.40
, pp. 1102-1109
-
-
Swotinsky, R.B.1
Steger, K.A.2
Sulis, C.3
Snyder, S.4
Craven, D.E.5
-
17
-
-
0034716479
-
Tolerability and side-effects of post-exposure prophylaxis for HIV infection
-
Parkin JM, Murphy M, Anderson J, El-Gadi S, Forster G, Pinching AJ. Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet 2000;355:722-3.
-
(2000)
Lancet
, vol.355
, pp. 722-723
-
-
Parkin, J.M.1
Murphy, M.2
Anderson, J.3
El-Gadi, S.4
Forster, G.5
Pinching, A.J.6
-
18
-
-
0034728916
-
Post-exposure prophylaxis for HIV infection
-
Puro V. Post-exposure prophylaxis for HIV infection [Letter]. Lancet 2000;355:1556-7.
-
(2000)
Lancet
, vol.355
, pp. 1556-1557
-
-
Puro, V.1
-
19
-
-
0034940153
-
Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV
-
Lee LM, Henderson DK. Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV. Drug Saf 2001;24:587-97.
-
(2001)
Drug Saf
, vol.24
, pp. 587-597
-
-
Lee, L.M.1
Henderson, D.K.2
-
20
-
-
0033731145
-
Antiretroviral prophylaxis of health care workers at two urban medical centers
-
Russi M, Buitrago M, Goulet J, et al. Antiretroviral prophylaxis of health care workers at two urban medical centers. J Occup Environ Med 2000;42:1092-100.
-
(2000)
J Occup Environ Med
, vol.42
, pp. 1092-1100
-
-
Russi, M.1
Buitrago, M.2
Goulet, J.3
-
21
-
-
0036119587
-
One-year study of occupational human immunodeficiency virus postexposure prophylaxis
-
Garb JR. One-year study of occupational human immunodeficiency virus postexposure prophylaxis. J Occup Environ Med 2002;44:265-70.
-
(2002)
J Occup Environ Med
, vol.44
, pp. 265-270
-
-
Garb, J.R.1
-
22
-
-
0034946336
-
Pan-Thames survey of occupational exposure to HIV and the use of post-exposure prophylaxis in 71 NHS trusts
-
Grime PR, Risi L, Binns C, Carruthers JR, Williams S. Pan-Thames survey of occupational exposure to HIV and the use of post-exposure prophylaxis in 71 NHS trusts. J Infect 2001;42:27-32.
-
(2001)
J Infect
, vol.42
, pp. 27-32
-
-
Grime, P.R.1
Risi, L.2
Binns, C.3
Carruthers, J.R.4
Williams, S.5
-
23
-
-
29344450056
-
-
Adverse drug reactions associated with PEP [Poster]. Boston, Massachusetts, February Poster no. 711
-
Puro V, DeCarli G, Soldani F, et al. Adverse drug reactions associated with PEP [Poster]. In: Program and Abstracts of the 10th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, February 2003. Poster no. 711.
-
(2003)
Program and Abstracts of the 10th Conference on Retroviruses and Opportunistic Infections
-
-
Puro, V.1
DeCarli, G.2
Soldani, F.3
-
24
-
-
3042784340
-
Unexpected drug interactions and adverse events with antiretroviral drugs
-
Moyle G, Boffito M. Unexpected drug interactions and adverse events with antiretroviral drugs. Lancet 2004;364:8-10.
-
(2004)
Lancet
, vol.364
, pp. 8-10
-
-
Moyle, G.1
Boffito, M.2
-
25
-
-
0038205534
-
Progress in pharmacology and drug interactions from the 10th CROI
-
Andrade A, Flexner C. Progress in pharmacology and drug interactions from the 10th CROI. Hopkins HIV Rep 2003;15:7,11.
-
(2003)
Hopkins HIV Rep
, vol.15
, pp. 7
-
-
Andrade, A.1
Flexner, C.2
-
26
-
-
2942724563
-
Genes, ethnicity, and efavirenz response: Clinical pharmacology update from the 11th CROI
-
Andrade A, Flexner C. Genes, ethnicity, and efavirenz response: clinical pharmacology update from the 11th CROI. Hopkins HIV Rep 2004;16:1-7.
-
(2004)
Hopkins HIV Rep
, vol.16
, pp. 1-7
-
-
Andrade, A.1
Flexner, C.2
-
27
-
-
67649510918
-
-
University of California at San Francisco Center for HIV Information. Database of antiretroviral drug interactions. Available at http://hivinsite. ucsf.edu/InSite?page=ar-00-02.
-
Database of Antiretroviral Drug Interactions
-
-
-
28
-
-
0037223881
-
Drug interactions between antiretroviral drugs and comedicated agents
-
de Maat MM, Ekhart GC, Huitema AD, Koks CH, Mulder JW, Beijnen JH. Drug interactions between antiretroviral drugs and comedicated agents. Clin Pharmacokinet 2003;42:223-82.
-
(2003)
Clin Pharmacokinet
, vol.42
, pp. 223-282
-
-
De Maat, M.M.1
Ekhart, G.C.2
Huitema, A.D.3
Koks, C.H.4
Mulder, J.W.5
Beijnen, J.H.6
-
29
-
-
0036437783
-
Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection
-
Fichtenbaum CJ, Gerber JG. Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection. Clin Pharmacokinet 2002;41:1195-211.
-
(2002)
Clin Pharmacokinet
, vol.41
, pp. 1195-1211
-
-
Fichtenbaum, C.J.1
Gerber, J.G.2
-
30
-
-
0036511638
-
Understanding drug-drug interactions in the management of HIV disease
-
Edmunds-Obguokiri T. Understanding drug-drug interactions in the management of HIV disease. HIV Clin 2002;14:1-4.
-
(2002)
HIV Clin
, vol.14
, pp. 1-4
-
-
Edmunds-Obguokiri, T.1
-
31
-
-
0036148774
-
HIV drug interactions: The good, the bad, and the other
-
Rainey PM. HIV drug interactions: the good, the bad, and the other. Ther Drug Monit 2002;24:26-31.
-
(2002)
Ther Drug Monit
, vol.24
, pp. 26-31
-
-
Rainey, P.M.1
-
32
-
-
0035188870
-
Pharmacokinetic and other drug interactions in patients with AIDS
-
Dasgupta A, Okhuysen PC. Pharmacokinetic and other drug interactions in patients with AIDS. Ther Drug Monit 2001;23:591-605.
-
(2001)
Ther Drug Monit
, vol.23
, pp. 591-605
-
-
Dasgupta, A.1
Okhuysen, P.C.2
-
33
-
-
0035967245
-
Interactions among drugs for HIV and opportunistic infections
-
Piscitelli SC, Gallicano KD. Interactions among drugs for HIV and opportunistic infections. N Engl J Med 2001;334:984-96.
-
(2001)
N Engl J Med
, vol.334
, pp. 984-996
-
-
Piscitelli, S.C.1
Gallicano, K.D.2
-
34
-
-
0037468373
-
Occupational exposure to HIV in health care settings
-
Gerberding JL. Occupational exposure to HIV in health care settings. N Engl J Med 2003;348:826-33.
-
(2003)
N Engl J Med
, vol.348
, pp. 826-833
-
-
Gerberding, J.L.1
-
35
-
-
3943104125
-
Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV
-
Bassett IV, Freedberg KA, Walensky RP. Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. Clin Infect Dis 2004;39:395-401.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 395-401
-
-
Bassett, I.V.1
Freedberg, K.A.2
Walensky, R.P.3
-
36
-
-
10744232997
-
Antiretroviral drug resistance in human immunodeficiency virus-infected source patients for occupational exposures to healthcare workers
-
Beltrami EM, Cheingsong R, Heneine WM, et al. Antiretroviral drug resistance in human immunodeficiency virus-infected source patients for occupational exposures to healthcare workers. Infect Control Hosp Epidemiol 2003;24:724-30.
-
(2003)
Infect Control Hosp Epidemiol
, vol.24
, pp. 724-730
-
-
Beltrami, E.M.1
Cheingsong, R.2
Heneine, W.M.3
-
37
-
-
0038234808
-
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 Recommendations of an International AIDS Society-USA Panel
-
Hirsch MS, Brun-Vezinet F, Clotet B, et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis 2003;37:113-28.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 113-128
-
-
Hirsch, M.S.1
Brun-Vezinet, F.2
Clotet, B.3
-
38
-
-
0034756776
-
Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis
-
Hawkins DA, Asboe D, Barlow K, Evans B. Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis. J Infect 2001;43:12-8.
-
(2001)
J Infect
, vol.43
, pp. 12-18
-
-
Hawkins, D.A.1
Asboe, D.2
Barlow, K.3
Evans, B.4
-
39
-
-
0037322805
-
Occupationally acquired human immunodeficiency virus (HIV) infection: National case surveillance data during 20 years of the HIV epidemic in the United States
-
Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 2003;24:86-96.
-
(2003)
Infect Control Hosp Epidemiol
, vol.24
, pp. 86-96
-
-
Do, A.N.1
Ciesielski, C.A.2
Metler, R.P.3
Hammett, T.A.4
Li, J.5
Fleming, P.L.6
-
40
-
-
84858525591
-
-
Data to the end of December London, UK: Health Protection Agency Centre for Infections and Collaborators
-
Health Protection Agency Centre for Infections and Collaborators. Occupational transmission of HIV: summary of published reports. March 2005 edition. Data to the end of December 2002. London, UK: Health Protection Agency Centre for Infections and Collaborators. Available at http://www.hpa.org.uk/ infections/topics_az/hiv_and_sti/hiv/occupational.htm.
-
(2002)
Occupational Transmission of HIV: Summary of Published Reports. March 2005 Edition
-
-
-
41
-
-
1242276103
-
Genotypic resistance tests for the management of postexposure prophylaxis
-
Puro V. Genotypic resistance tests for the management of postexposure prophylaxis. Scand J Infect Dis Suppl 2003;(35 Suppl):106:93-8.
-
(2003)
Scand J Infect Dis Suppl
, vol.106
, Issue.35 SUPPL.
, pp. 93-98
-
-
Puro, V.1
-
42
-
-
0022426871
-
Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace
-
CDC. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 1985;34:681-6, 691-5.
-
(1985)
MMWR
, vol.34
, pp. 681-686
-
-
-
43
-
-
29344455372
-
Barriers to and facilitators of implementing U.S. Public Health Service (PHS) guidelines on occupational exposure management by emergency physicians
-
Arlington, Virginia, April 5-8, Abstract no. 240
-
Panlilio AL, Sinkowitz-Cochran R, Grady MA, Cardo DM. Barriers to and facilitators of implementing U.S. Public Health Service (PHS) guidelines on occupational exposure management by emergency physicians [Abstract]. In: Program and Abstracts of the 13th annual meeting of the Society for Health-care Epidemiology of America, Arlington, Virginia, April 5-8, 2003. Abstract no. 240.
-
(2003)
Program and Abstracts of the 13th Annual Meeting of the Society for Health-care Epidemiology of America
-
-
Panlilio, A.L.1
Sinkowitz-Cochran, R.2
Grady, M.A.3
Cardo, D.M.4
-
45
-
-
0035099551
-
A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers
-
King AM, Osterwalder JJ, Vernazza PL. A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers. Swiss Med Wkly 2001;131:10-3.
-
(2001)
Swiss Med Wkly
, vol.131
, pp. 10-13
-
-
King, A.M.1
Osterwalder, J.J.2
Vernazza, P.L.3
-
47
-
-
2942527540
-
Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of health-care workers
-
Puro V, Francisci D, Sighinolfi L, et al. Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of health-care workers. J Hosp Infect 2004;57:179-82.
-
(2004)
J Hosp Infect
, vol.57
, pp. 179-182
-
-
Puro, V.1
Francisci, D.2
Sighinolfi, L.3
-
48
-
-
29344470417
-
-
Post-exposure prophylaxis (PEP) in health care workers (HCWs) after exposure to an HIV-infected source patient (SP) [Poster]. San Francisco, California, February 8-11, Poster no. 887
-
Dong BJ, Harvey A, Aranow RA, et al. Post-exposure prophylaxis (PEP) in health care workers (HCWs) after exposure to an HIV-infected source patient (SP) [Poster]. In: Program and Abstract of the 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, California, February 8-11, 2004. Poster no. 887.
-
(2004)
Program and Abstract of the 11th Conference on Retroviruses and Opportunistic Infections
-
-
Dong, B.J.1
Harvey, A.2
Aranow, R.A.3
-
49
-
-
0025974954
-
Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner
-
Shih C-C, Kaneshima H, Rabin L, et al. Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J Infect Dis 1991;163:625-7.
-
(1991)
J Infect Dis
, vol.163
, pp. 625-627
-
-
Shih, C.-C.1
Kaneshima, H.2
Rabin, L.3
-
50
-
-
0028791836
-
Prevention of SIV infection in macaques by (R)-9-(2- phosphonylmethoxypropyl) adenine
-
Tsai C-C, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine. Science 1995;270:1197-9.
-
(1995)
Science
, vol.270
, pp. 1197-1199
-
-
Tsai, C.-C.1
Follis, K.E.2
Sabo, A.3
-
51
-
-
0031979775
-
mne infection depends critically on timing of initiation and duration of treatment
-
mne infection depends critically on timing of initiation and duration of treatment. J Virol 1998;72:4265-73.
-
(1998)
J Virol
, vol.72
, pp. 4265-4273
-
-
Tsai, C.-C.1
Emau, P.2
Follis, K.E.3
-
52
-
-
0033814480
-
Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2)
-
Otten RA, Smith DK, Adams DR, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol 2000;74:9771-5.
-
(2000)
J Virol
, vol.74
, pp. 9771-9775
-
-
Otten, R.A.1
Smith, D.K.2
Adams, D.R.3
-
53
-
-
0032770948
-
Severe hepatic failure related to nevirapine treatment
-
Cattelan AM, Erne E, Slatino A, et al. Severe hepatic failure related to nevirapine treatment. Clin Infect Dis 1999;29:455-6.
-
(1999)
Clin Infect Dis
, vol.29
, pp. 455-456
-
-
Cattelan, A.M.1
Erne, E.2
Slatino, A.3
-
54
-
-
0034614159
-
Adverse effects associated with use of nevirapine in HIV postexposure for 2 health care workers
-
Johnson S, Baraboutis JG, Sha BE, Proia LA, Kessler HA. Adverse effects associated with use of nevirapine in HIV postexposure for 2 health care workers [Letter]. JAMA 2000;284:2722-3.
-
(2000)
JAMA
, vol.284
, pp. 2722-2723
-
-
Johnson, S.1
Baraboutis, J.G.2
Sha, B.E.3
Proia, L.A.4
Kessler, H.A.5
-
55
-
-
0000544290
-
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures - Worldwide, 1997-2000
-
CDC. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures - worldwide, 1997-2000. MMWR 2001;49:1153-6.
-
(2001)
MMWR
, vol.49
, pp. 1153-1156
-
-
-
56
-
-
0030900781
-
Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury
-
Ridzon R, Gallagher K, Ciesielski C, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med 1997;336:919-22.
-
(1997)
N Engl J Med
, vol.336
, pp. 919-922
-
-
Ridzon, R.1
Gallagher, K.2
Ciesielski, C.3
-
57
-
-
0030744135
-
Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus
-
Ciesielski CA, Metler RP. Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus. Am J Med 1997;102(Suppl 5B):115-6.
-
(1997)
Am J Med
, vol.102
, Issue.SUPPL. 5B
, pp. 115-116
-
-
Ciesielski, C.A.1
Metler, R.P.2
-
58
-
-
0030795491
-
Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure
-
Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997;102(Suppl 5B):117-24.
-
(1997)
Am J Med
, vol.102
, Issue.SUPPL. 5B
, pp. 117-124
-
-
Busch, M.P.1
Satten, G.A.2
-
59
-
-
0032915408
-
Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: A case series
-
Rich JD, Merriman NA, Mylonakis E, et al. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med 1999;130:37-9.
-
(1999)
Ann Intern Med
, vol.130
, pp. 37-39
-
-
Rich, J.D.1
Merriman, N.A.2
Mylonakis, E.3
-
60
-
-
3242802876
-
HIV RNA testing in the context of nonoccupational postexposure prophylaxis
-
Roland ME, Elbeik TA, Kahn JO, et al. HIV RNA testing in the context of nonoccupational postexposure prophylaxis. J Infect Dis 2004;190:598-604.
-
(2004)
J Infect Dis
, vol.190
, pp. 598-604
-
-
Roland, M.E.1
Elbeik, T.A.2
Kahn, J.O.3
-
61
-
-
0028824942
-
Occupational exposure of health carMorbidity and Mortality Weekly Report (MMWR)e workers (HCWs) to human immunodeficiency virus (HIV): Stress reactions and counseling interventions
-
Armstrong K, Gorden R, Santorella G. Occupational exposure of health carMorbidity and Mortality Weekly Report (MMWR)e workers (HCWs) to human immunodeficiency virus (HIV): stress reactions and counseling interventions. Social Work in Health Care 1995;21:61-80.
-
(1995)
Social Work in Health Care
, vol.21
, pp. 61-80
-
-
Armstrong, K.1
Gorden, R.2
Santorella, G.3
-
62
-
-
0037098681
-
Anxiety in health care workers after exposure to potentially HIV-contaminated blood or body fluids
-
Meienberg F, Bucher HC, Sponagel L, Zinkernagel C, Gyr N, Battegay M. Anxiety in health care workers after exposure to potentially HIV-contaminated blood or body fluids. Swiss Med Wkly 2002;132:321-4.
-
(2002)
Swiss Med Wkly
, vol.132
, pp. 321-324
-
-
Meienberg, F.1
Bucher, H.C.2
Sponagel, L.3
Zinkernagel, C.4
Gyr, N.5
Battegay, M.6
-
63
-
-
29344454787
-
Postmarketing reporting of adverse drug experiences
-
21CFR314.80
-
Food and Drug Administration. 21CFR314.80. Postmarketing reporting of adverse drug experiences. Code of Federal Regulations 2005;5:114-7.
-
(2005)
Code of Federal Regulations
, vol.5
, pp. 114-117
-
-
|